First stem cellderived implant for diabetes

摘要

TWO people with type 1 diabetes have received stem cell-derived implants to treat their condition for the first time. About 10 per cent of the 422 million people with diabetes worldwide have type 1. This is caused by the immune system destroying the islet cells in the pancreas that make insulin. For more than 15 years, researchers have been trying to find a way to replace these using stem cells.